久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/06/19 | 3,655 | 3,685 | 3,618 | 3,636 | -20 | -0.5% | 126,100 |
2023/06/16 | 3,570 | 3,658 | 3,568 | 3,656 | +115 | +3.2% | 525,600 |
2023/06/15 | 3,565 | 3,573 | 3,541 | 3,541 | -45 | -1.3% | 220,300 |
2023/06/14 | 3,619 | 3,623 | 3,580 | 3,586 | -29 | -0.8% | 168,800 |
2023/06/13 | 3,640 | 3,646 | 3,614 | 3,615 | -34 | -0.9% | 164,800 |
2023/06/12 | 3,648 | 3,660 | 3,633 | 3,649 | +26 | +0.7% | 123,900 |
2023/06/09 | 3,599 | 3,627 | 3,586 | 3,623 | +35 | +1% | 144,300 |
2023/06/08 | 3,600 | 3,624 | 3,572 | 3,588 | -5 | -0.1% | 127,700 |
2023/06/07 | 3,653 | 3,654 | 3,582 | 3,593 | -56 | -1.5% | 135,800 |
2023/06/06 | 3,608 | 3,651 | 3,582 | 3,649 | +19 | +0.5% | 117,500 |
2023/06/05 | 3,637 | 3,655 | 3,613 | 3,630 | +5 | +0.1% | 141,800 |
2023/06/02 | 3,585 | 3,625 | 3,585 | 3,625 | +35 | +1% | 92,900 |
2023/06/01 | 3,585 | 3,615 | 3,575 | 3,590 | ±0 | ±0% | 88,200 |
2023/05/31 | 3,595 | 3,615 | 3,555 | 3,590 | -55 | -1.5% | 267,400 |
2023/05/30 | 3,685 | 3,700 | 3,615 | 3,645 | -40 | -1.1% | 127,400 |
2023/05/29 | 3,705 | 3,710 | 3,675 | 3,685 | -10 | -0.3% | 100,200 |
2023/05/26 | 3,790 | 3,790 | 3,685 | 3,695 | -100 | -2.6% | 111,600 |
2023/05/25 | 3,780 | 3,805 | 3,765 | 3,795 | +15 | +0.4% | 97,700 |
2023/05/24 | 3,785 | 3,805 | 3,765 | 3,780 | -5 | -0.1% | 60,600 |
2023/05/23 | 3,820 | 3,820 | 3,765 | 3,785 | -20 | -0.5% | 59,700 |
2023/05/22 | 3,780 | 3,815 | 3,775 | 3,805 | +25 | +0.7% | 52,200 |
2023/05/19 | 3,790 | 3,790 | 3,765 | 3,780 | -20 | -0.5% | 85,600 |
2023/05/18 | 3,820 | 3,820 | 3,775 | 3,800 | -5 | -0.1% | 99,500 |
2023/05/17 | 3,800 | 3,830 | 3,800 | 3,805 | -5 | -0.1% | 88,600 |
2023/05/16 | 3,800 | 3,815 | 3,785 | 3,810 | +25 | +0.7% | 86,600 |
2023/05/15 | 3,780 | 3,790 | 3,755 | 3,785 | +30 | +0.8% | 72,300 |
2023/05/12 | 3,735 | 3,765 | 3,715 | 3,755 | +15 | +0.4% | 122,700 |
2023/05/11 | 3,765 | 3,780 | 3,730 | 3,740 | -70 | -1.8% | 112,100 |
2023/05/10 | 3,820 | 3,820 | 3,785 | 3,810 | -20 | -0.5% | 116,200 |
2023/05/09 | 3,790 | 3,830 | 3,790 | 3,830 | +45 | +1.2% | 101,000 |
2023/05/08 | 3,765 | 3,790 | 3,760 | 3,785 | +20 | +0.5% | 120,900 |
2023/05/02 | 3,790 | 3,795 | 3,755 | 3,765 | ±0 | ±0% | 101,000 |
2023/05/01 | 3,780 | 3,805 | 3,765 | 3,765 | +15 | +0.4% | 109,700 |
2023/04/28 | 3,735 | 3,760 | 3,725 | 3,750 | +65 | +1.8% | 172,100 |
2023/04/27 | 3,680 | 3,700 | 3,670 | 3,685 | -35 | -0.9% | 172,800 |
2023/04/26 | 3,675 | 3,725 | 3,655 | 3,720 | +40 | +1.1% | 174,200 |
2023/04/25 | 3,705 | 3,715 | 3,670 | 3,680 | ±0 | ±0% | 93,400 |
2023/04/24 | 3,720 | 3,720 | 3,670 | 3,680 | -5 | -0.1% | 76,300 |
2023/04/21 | 3,710 | 3,715 | 3,680 | 3,685 | -25 | -0.7% | 122,700 |
2023/04/20 | 3,690 | 3,720 | 3,665 | 3,710 | +15 | +0.4% | 102,800 |
2023/04/19 | 3,720 | 3,720 | 3,685 | 3,695 | ±0 | ±0% | 79,800 |
2023/04/18 | 3,680 | 3,730 | 3,675 | 3,695 | +35 | +1% | 105,200 |
2023/04/17 | 3,730 | 3,760 | 3,655 | 3,660 | -80 | -2.1% | 183,000 |
2023/04/14 | 3,720 | 3,770 | 3,715 | 3,740 | -90 | -2.3% | 194,000 |
2023/04/13 | 3,805 | 3,845 | 3,780 | 3,830 | +40 | +1.1% | 166,000 |
2023/04/12 | 3,790 | 3,800 | 3,765 | 3,790 | +55 | +1.5% | 81,200 |
2023/04/11 | 3,760 | 3,785 | 3,725 | 3,735 | +5 | +0.1% | 101,000 |
2023/04/10 | 3,765 | 3,780 | 3,715 | 3,730 | -20 | -0.5% | 90,500 |
2023/04/07 | 3,750 | 3,770 | 3,740 | 3,750 | -40 | -1.1% | 83,400 |
2023/04/06 | 3,745 | 3,795 | 3,730 | 3,790 | +30 | +0.8% | 115,800 |
501~
550
件表示中 / 3734件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 400,400円 | +5.8% | +1.2% | 3.00% | 13.28倍 | 1.06倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 206,200円 | +8.4% | +0.2% | 2.04% | 14.98倍 | 1.80倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 89,200円 | -11.0% | +206.6% | 0.00% | 8.86倍 | 2.09倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 350,600円 | +3.8% | -19.9% | 3.88% | 11.39倍 | 0.88倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 312,600円 | +8.0% | -15.3% | 3.97% | 8.78倍 | 0.86倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム